Patrick Plésiat

954 total citations
11 papers, 757 citations indexed

About

Patrick Plésiat is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Patrick Plésiat has authored 11 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Medicine, 6 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Patrick Plésiat's work include Antibiotic Resistance in Bacteria (8 papers), Bacterial biofilms and quorum sensing (5 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Patrick Plésiat is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Bacterial biofilms and quorum sensing (5 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Patrick Plésiat collaborates with scholars based in France, United States and Switzerland. Patrick Plésiat's co-authors include Didier Hocquet, Katy Jeannot, Farid El Garch, Patrice Nordmann, Mara Sobel, Keith Poole, Julio Aires, Christelle Vogne, Ludovic Cabanne and Thilo Köhler and has published in prestigious journals such as PLoS ONE, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Patrick Plésiat

11 papers receiving 737 citations

Peers

Countries citing papers authored by Patrick Plésiat

Since Specialization

Citations

This map shows the geographic impact of Patrick Plésiat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Plésiat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Plésiat more than expected).

Fields of papers citing papers by Patrick Plésiat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Plésiat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Plésiat. The network helps show where Patrick Plésiat may publish in the future.

Co-authorship network of co-authors of Patrick Plésiat

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Plésiat. A scholar is included among the top collaborators of Patrick Plésiat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Plésiat. Patrick Plésiat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community 2019 ·Antimicrobial Agents and Chemotherapy ·Anaïs Potron, Didier Hocquet, (unknown), Patrick Plésiat, Xavier Bertrand, Benoı̂t Valot	12
2	Pyomelanin‐producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins 2016 ·Environmental Microbiology ·Didier Hocquet, Marie Petitjean, Laurence Rohmer, Benoı̂t Valot, Hemantha D. Kulasekara, (unknown), Xavier Bertrand, Patrick Plésiat, Thilo Köhler, Alix Pantel, Michael A. Jacobs, Lucas R. Hoffman, Samuel I. Miller	42
3	Evidence for Induction of Integron-Based Antibiotic Resistance by the SOS Response in a Clinical Setting 2012 ·PLoS Pathogens ·Didier Hocquet, Catherine Llanes, Michelle Thouverez, Hemantha D. Kulasekara, Xavier Bertrand, Patrick Plésiat, Didier Mazel, Samuel I. Miller	99
4	Human Cysteine Cathepsins Are Not Reliable Markers of Infection by Pseudomonas aeruginosa in Cystic Fibrosis 2011 ·PLoS ONE ·Clément Naudin, (unknown), G. Couetdic, Patrick Plésiat, Aneta Szymańska, (unknown), Francis Gauthier, Franciszek Kasprzykowski, Fabien Lecaille, Gilles Lalmanach	23
5	Resistance and Virulence of Pseudomonas aeruginosa Clinical Strains Overproducing the MexCD-OprJ Efflux Pump 2008 ·Antimicrobial Agents and Chemotherapy ·Katy Jeannot, Sylvie Elsen, Thilo Köhler, Ina Attrée, Christian van Delden, Patrick Plésiat	104
6	Naturally Occurring Class A ß-Lactamases from the Burkholderia cepacia Complex 2008 ·Antimicrobial Agents and Chemotherapy ·Laurent Poirel, José Manuel Rodríguez-Martínez, Patrick Plésiat, Patrice Nordmann	46
7	Pseudomonas aeruginosa May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections 2007 ·Antimicrobial Agents and Chemotherapy ·Didier Hocquet, P. Berthelot, Micheline Roussel‐Delvallez, Roger Favre, Katy Jeannot, Odile Bajolet, N. Marty, Florence Grattard, Patricia Mariani‐Kurkdjian, Édouard Bingen, Marie-Odile Husson, G. Couetdic, Patrick Plésiat	82
8	Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa 2006 ·Antimicrobial Agents and Chemotherapy ·Didier Hocquet, Patrice Nordmann, Farid El Garch, Ludovic Cabanne, Patrick Plésiat	110
9	Induction of the MexXY Efflux Pump in Pseudomonas aeruginosa Is Dependent on Drug-Ribosome Interaction 2005 ·Journal of Bacteriology ·Katy Jeannot, Mara Sobel, Farid El Garch, Keith Poole, Patrick Plésiat	123
10	L'efflux actif des antibiotiques et la résistance bactérienne: état de la question et implications 2005 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·Narcisa Mesaros, Françoise Van Bambeke, Laëtitia Avrain, (unknown), R. Vanhoof, Patrick Plésiat, Paul M. Tulkens	2
11	Role of the Multidrug Efflux System MexXY in the Emergence of Moderate Resistance to Aminoglycosides among Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis 2004 ·Antimicrobial Agents and Chemotherapy ·Christelle Vogne, Julio Aires, (unknown), Didier Hocquet, Patrick Plésiat	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact